RARS expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.076200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.160400E-01
Normal-vs-Stage2
2.980200E-01
Normal-vs-Stage3
9.135600E-01
Normal-vs-Stage4
1.574210E-01
Stage1-vs-Stage2
9.557400E-01
Stage1-vs-Stage3
5.130000E-01
Stage1-vs-Stage4
6.143800E-01
Stage2-vs-Stage3
3.309800E-01
Stage2-vs-Stage4
6.554600E-01
Stage3-vs-Stage4
4.320200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.239400E-01
Normal-vs-AfricanAmerican
3.875800E-01
Normal-vs-Asian
3.267400E-01
Caucasian-vs-AfricanAmerican
8.052400E-01
Caucasian-vs-Asian
4.642800E-01
AfricanAmerican-vs-Asian
5.094400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.356800E-01
Normal-vs-Female
2.928000E-01
Male-vs-Female
6.966000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.438600E-01
Normal-vs-Age(41-60Yrs)
1.040240E-01
Normal-vs-Age(61-80Yrs)
4.711400E-01
Normal-vs-Age(81-100Yrs)
3.512200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.857380E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.831400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.180000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.218050E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.373800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.909400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.595200E-01
Normal-vs-Daily Drinker
5.565600E-01
Normal-vs-Weekly Drinker
3.865000E-01
Normal-vs-Occasional Drinker
1.423370E-01
Normal-vs-Social Drinker
2.156500E-02
Non Drinker-vs-Daily Drinker
9.042800E-01
Non Drinker-vs-Weekly Drinker
6.487200E-01
Non Drinker-vs-Occasional Drinker
3.699600E-01
Non Drinker-vs-Social Drinker
2.217400E-01
Daily Drinker-vs-Weekly Drinker
5.676000E-01
Daily Drinker-vs-Occasional Drinker
2.848200E-01
Daily Drinker-vs-Social Drinker
1.805990E-01
Weekly Drinker-vs-Occasional Drinker
7.378400E-01
Weekly Drinker-vs-Social Drinker
6.683800E-01
Occasional Drinker-vs-Social Drinker
9.050600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.262400E-01
Normal-vs-Grade 2
7.319400E-01
Normal-vs-Grade 3
6.923800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.847900E-04
Grade 1-vs-Grade 3
1.573070E-04
Grade 1-vs-Grade 4
9.262400E-01
Grade 2-vs-Grade 3
3.492400E-01
Grade 2-vs-Grade 4
7.319400E-01
Grade 3-vs-Grade 4
6.923800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.270000E-01
Normal-vs-NonDiabetic
2.634600E-01
Diabetic-vs-NonDiabetic
6.156000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.344400E-01
Normal-vs-NoPancreatitis
3.527200E-01
Pancreatitis-vs-NoPancreatitis
1.515240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.549200E-01
Normal-vs-N1
3.272800E-01
N0-vs-N1
7.711800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.712300E-02
Normal-vs-TP53-NonMutant
3.832000E-01
TP53-Mutant-vs-TP53-NonMutant
6.560400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
